The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
about
Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling studyPotential Biases in Estimating Absolute and Relative Case-Fatality Risks during OutbreaksUniversal immunity to influenza must outwit immune evasionThe epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong KongCase fatality risk of influenza A (H1N1pdm09): a systematic reviewIncidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, FrancePrevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimationSeroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccineEstimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance dataEstimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.Two years after pandemic influenza A/2009/H1N1: what have we learned?Effects of influenza antivirals on individual and population immunity over many epidemic waves.Public health. Surveillance of animal influenza for pandemic preparedness.Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USAEpidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study.Seroprevalence to influenza A(H1N1) 2009 virus--where are we?Incidence of symptomatic A(H1N1)pdm09 influenza during the pandemic and post-pandemic periods in a rural Indian community.Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong.Hospitalization risk of the 2009 H1N1 pandemic cases in Hong Kong.Inferring influenza infection attack rate from seroprevalence dataPhylogenetic evidence for a mild H1 pandemic in the early 1900s.Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infectionOptimizing the precision of case fatality ratio estimates under the surveillance pyramid approach.A Bayesian inferential approach to quantify the transmission intensity of disease outbreak.Impact of the 2009 H1N1 Pandemic on Age-Specific Epidemic Curves of Other Respiratory Viruses: A Comparison of Pre-Pandemic, Pandemic and Post-Pandemic Periods in a Subtropical City.Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protectionEconomic Evaluation of Individual School Closure Strategies: The Hong Kong 2009 H1N1 Pandemic.CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.The impact of stratified immunity on the transmission dynamics of influenza.Did modeling overestimate the transmission potential of pandemic (H1N1-2009)? Sample size estimation for post-epidemic seroepidemiological studiesRelative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.The seroprevalence of pandemic influenza H1N1 (2009) virus in China.Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico.Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece.Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period.Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis
P2860
Q21144595-92F023E3-95EE-4B2E-9636-BEA29DE6DA36Q26800248-CCDAF2CB-474E-4DC1-970A-0041A66C564EQ26991896-7BE302AA-177C-4741-87A4-AFE5F1661684Q27000773-81FE2BF9-1A05-4F38-86B0-6F21B404E14FQ27004559-DB922680-EF16-4130-8E18-0B4CE8E1C504Q28730980-B7E5C414-28FA-4FAA-A9AA-99EFA579878AQ28741061-7C0AFD98-F3F9-4315-A1DE-87773F4AE1D0Q28742436-8C43D756-41B3-4EAB-BB7D-D2B54625F3E9Q28742786-A8D75986-CBA9-4361-B881-3C8BC3A39495Q28742920-3C8F4D38-987F-459D-AA46-EDA08F659290Q30000940-7E2C9D75-41AA-4D39-9A8E-F2EB705BD89CQ30223476-0D84DEC9-B907-42AD-BC5F-6A5FFC0E2276Q30224656-EA04E82A-BE21-489E-A24E-0D7121F27740Q30224681-33237B38-02CA-49F5-BF90-7802DDDC748AQ30224737-6068950F-8A76-480E-8FD3-D0F10BC17100Q30224919-22BFAAEB-E172-44AD-BFD1-CC7AB398FA72Q30226505-60C5713D-A7C3-48FC-BD8A-F82F09D1E80CQ30226546-ABE0B60D-841B-49B5-80B8-9C98660183E0Q30354227-03246124-61CE-4BB9-AF3B-0FF4FD4A552BQ30357318-60C92964-4EFC-4AAC-9025-C71C082DB760Q30357935-F8529DAD-79A7-4171-87A1-56FB80DAE7CDQ30361006-A14404E5-D65C-43F8-A636-476B566B7885Q30363410-29B084E7-C766-4FF6-BC05-9FC292FC8FB7Q30366832-8BD51E67-AF1A-43EB-B2A9-47D87AFCE2B0Q30367189-81F781DC-1D2C-4873-A17F-372F94B77AA6Q30372816-6132D2A2-89B2-4EEC-826E-2F318081C157Q30374277-C4868844-E5E4-444A-9A9F-57172799A48CQ30377381-5F74B3D2-3809-4A23-9F42-23B02BDAA190Q30383964-D63385BF-8237-4F96-B7A7-35B6C9848F55Q30390554-655D41B9-3FF6-40F5-972F-54F546FAF4F2Q30398715-D246ACF3-D17C-456A-B9E3-55384910A30BQ30400970-5CA98CED-33A0-40F1-85A1-43397B940C09Q30401351-FBDD22A9-B58D-4E26-B843-B4F20EEFEF58Q30401871-9CA87F8F-DEC9-4807-98D8-3A0B067AD302Q30402040-30B2A4A0-B297-40F6-9507-2160F625690BQ30402225-F38EEB26-AC4B-4934-B8C5-1AB165579B13Q30403311-52B6E8C8-4D1F-4F4C-981B-904070C6F468Q30404078-89A6FE7F-6E77-4FB2-80D6-6E11AAFF32BAQ30404184-AF751358-97DE-4A55-BE10-E105A6FD65E8Q30404745-32CBB257-C39E-49BD-9B64-9F73F7F3BC0F
P2860
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@ast
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@en
type
label
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@ast
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@en
prefLabel
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@ast
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@en
P2093
P2860
P50
P356
P1476
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.
@en
P2093
Angela L Shen
Che Kit Lin
Cheuk Kwong Lee
Edward S K Ma
Lai Ming Ho
Steven Riley
Thomas Tsang
Yu-Lung Lau
P2860
P304
P356
10.1086/656740
P407
P577
2010-11-01T00:00:00Z